Platelet-Activating Factor (PAF) Receptor Antagonism Modulates Inflammatory Signaling in Experimental Uveitis

References

• Suttorp-Schulten MS, Rothova A. The possible impact of uveitis on blindness: a literature review. Br J Ophthalmol. 1996;8:844–48. doi:10.1136/bjo.80.9.844.
   Web of Science ®Google Scholar
• Gritz D. Incidence and prevalence of uveitis in Northern California: the Northern California Epidemiology of Uveitis Study. Ophthalmology. 2004;111:491–500. doi:10.1016/j.ophtha.2003.06.014.
   PubMed Web of Science ®Google Scholar
• Rau NA, Wu GS. Free radical mediated photoreceptor damage in uveitis. Prog Retina Eye Res. 2000;19:41–68. doi:10.1016/S1350-9462(99)00003-8.
   PubMed Web of Science ®Google Scholar
• Sen HN, Vitale S, Gangaputra SS, Nussenblatt RB, Liesegang TL, Levy-Clarke GA, Rosenbaum JT, Suhler EB, Thorne JE, Foster CS, et al. Periocular corticosteroid injections in uveitis: effects and complications. Ophthalmology. 2014; 121(11): 2275–86. doi:10.1016/j.ophtha.2014.05.021.
   Web of Science ®Google Scholar
• Imrie F, Dick A. Biologics in the treatment of uveitis. Curr Opin Ophthalmol. 2007;18:481–86. doi:10.1097/ICU.0b013e3282f03d42.
   PubMed Web of Science ®Google Scholar
• Jaffe GJ, Dick AD, Brézin AP, Nguyen QD, Thorne JE, Kestelyn P, Barisani-Asenbauer T, Franco P, Heiligenhaus A, Scales D, et al. Adalimumab in patients with active noninfectious uveitis. N Engl J Med. 2016;375:932–43. doi:10.1056/NEJMoa1509852.
   PubMed Web of Science ®Google Scholar
• Nitoda E, Moschos MM, Mavragani CP, Koutsilieris M. Ocular actions of platelet-activating factor: clinical implications. Expert Opin Ther Targets. 2012;16:1027–39. doi:10.1517/14728222.2012.712961.
   PubMed Web of Science ®Google Scholar
• Tsuji F, Shirasawa E. The role of platelet-activating factor in cell infiltration in endotoxin-induced uveitis in guinea pigs. Curr Eye Res. 1998;17:501–05. doi:10.1076/ceyr.17.5.501.5194.
   PubMed Web of Science ®Google Scholar
• Garland RC, Sun D, Zandi S, Xie F, Faez S, Tayyari F, Frimmel SA, Schering A, Nakao S, Hafezi-Moghadam A. Noninvasive molecular imaging reveals role of PAF in leukocyte-endothelial interaction in LPS-induced ocular vascular injury. Faseb J. 2011;25:1284–94. doi:10.1096/fj.10-160051.
   PubMed Web of Science ®Google Scholar
• Rosenbaum JT, Angell E, Wilson D, Broquet C, Boney RS, Braquet P. Intravitreally injected platelet activating factor induces retinitis in experimental animals. Curr Eye Res. 1999;18:342–48. doi:10.1076/ceyr.18.5.342.5346.
   PubMed Web of Science ®Google Scholar
• De Kozak Y, Faure JP, Thillaye B, Ruchoux MM, Doly M, Droy-Lefaix MT, Braquet P. Ginkgo biloba extract (EGb 761) and a platelet-activating factor antagonist protect the retina in experimental autoimmune uveoretinitis. Ocul Immunol Inflamm. 1994;2:231–37. doi:10.3109/09273949409057081.
   PubMedGoogle Scholar
• Bhosle VK, Rivera JC, Zhou TE, Omri S, Sanchez M, Hamel D, Zhu T, Rouget R, Rabea AA, Hou X, et al. Nuclear localization of platelet-activating factor receptor controls retinal neovascularization. Cell Discov. 2016;2:16017. doi:10.1038/celldisc.2016.17.
   PubMed Web of Science ®Google Scholar
• Zhang H, Yang Y, Takeda A, Yoshimura T, Oshima Y, Sonoda KH, Ishibashi T. A novel platelet-activating factor receptor antagonist inhibits choroidal neovascularization and subretinal fibrosis. PLoS One. 2013;8:e68173. doi:10.1371/journal.pone.0068173.
   PubMed Web of Science ®Google Scholar
• Lin N, Bazan HE, Braquet P, Bazan NG. Prolonged effects of a new platelet-activating factor antagonist on ocular vascular permeability in an endotoxin model of uveitis. Curr Eye Res. 1991;10:19–24. doi:10.3109/02713689109007607.
   PubMed Web of Science ®Google Scholar
• Cortina MS, Gordon WC, Lukiw WJ, Bazan NG. Oxidative stress-induced retinal damage up-regulates DNA polymerase gamma and 8-oxoguanine-DNA-glycosylase in photoreceptor synaptic mitochondria. Exp Eye Res. 2005;81:742–50. doi:10.1016/j.exer.2005.04.017.
   PubMed Web of Science ®Google Scholar
• He J, Bazan NG, Bazan HE. Alkali-induced corneal stromal melting prevention by a novel platelet activating factor receptor antagonist. Arch Ophthalmol. 2006;124:70–78. doi:10.1001/archopht.124.1.70.
   PubMed Web of Science ®Google Scholar
• Belayev L, Khoutorova L, Atkins K, Gordon WC, Alvarez-Builla J, Bazan NG. LAU-0901, a novel platelet-activating factor antagonist, is highly neuroprotective in cerebral ischemia. Exp Neurol. 2008;214:253–58. doi:10.1016/j.expneurol.2008.08.009.
   PubMed Web of Science ®Google Scholar
• Bazan NG. Synaptic lipid signaling: significance of polyunsaturated fatty acids and platelet-activating factor. J Lipid Res. 2003;44:2221–33. doi:10.1194/jlr.R300013-JLR200.
   PubMed Web of Science ®Google Scholar
• Couturier A, Bousquet E, Zhao M, Naud MC, Klein C, Jonet L, Tadayoni R, de Kozak Y, Behar-Cohen F. Anti-vascular endothelial growth factor acts on retinal microglia/macrophage activation in a rat model of ocular inflammation. Mol Vis. 2014;20:908–20.
   PubMed Web of Science ®Google Scholar
• R Core Team. R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. 2012; ISBN 3-900051-07-0, URL http://www.R-project.org/.
   Google Scholar
• D’Alessandro LP, Forster DJ, Rao NA. Anterior uveitis and hypopyon. Trans Am Ophthalmol Soc. 1991;89:303–11.
   PubMedGoogle Scholar
• Pepple KL, Choi WJ, Wilson L, Van Gelder RN, Wang RK. Quantitative assessment of anterior segment inflammation in a rat model of uveitis using spectral-domain optical coherence tomography. Invest Ophthalmol Vis Sci. 2016; 57:3567–75. doi:10.1167/iovs.16-19276.
   Google Scholar
• Bazan NG, Halabi A, Ertel M, Petasis NA. Neuroinflammation. In: Siegel G, Albers RW, Brady ST, Price DL eds. Basic neurochemistry: molecular, cellular and medical aspects. 8th ed. Burlington: Elsevier Academic Press; 2012.
   Google Scholar
• Bazan NG, Calandria JM, Serhan CN. Rescue and repair during photoreceptor cell renewal mediated by docosahexaenoic acid-derived neuroprotectin D1. J Lipid Res. 2010;51:2018–31. doi:10.1194/jlr.R001131.
   PubMed Web of Science ®Google Scholar
• Xu H, Jv F, Liversidge J, Ij C. Leukocyte trafficking in experimental autoimmune uveitis: breakdown of blood retinal barrier and upregulation of cellular adhesion molecules. Invest Ophthalmol Vis Sci. 2003;44:226–34. doi:10.1167/iovs.01-1202.
   PubMed Web of Science ®Google Scholar
• Xu H, Dawson R, Crane IJ, Liversidge J. Leukocyte diapedesis in vivo induces transient loss of tight junction protein at the blood retina barrier. Invest Ophthalmol Vis Sci. 2005;46:2487–94. doi:10.1167/iovs.04-1333.
   PubMed Web of Science ®Google Scholar
• Heil M, Clauss M, Suzuki K, Buschmann IR, Willuweit A, Fischer S, Schaper W. Vascular endothelial growth factor (VEGF) stimulates monocyte migration through endothelial monolayers via increased integrin expression. Eur J Cell Biol. 2000;79:850–57. doi:10.1078/0171-9335-00113.
   PubMed Web of Science ®Google Scholar
• Bazan HE, Tao Y, DeCoster MA, Bazan NG. Platelet-activating factor induces cyclooxygenase-2 gene expression in corneal epithelium. Requirement of calcium in the signal transduction pathway. Invest Ophthalmol Vis Sci. 1997;38:2492–501.
   PubMed Web of Science ®Google Scholar
• Belayev L, Khoutorova L, Atkins K, Cherqui A, Alvarez-Builla J, Bazan NG. LAU-0901, a novel platelet-activating factor-receptor antagonist, confers enduring neuroprotection in experimental focal cerebral ischemia in the rat. Brain Res. 2009;1253:184–90. doi:10.1016/j.brainres.2008.11.074.
   PubMed Web of Science ®Google Scholar